Earnings Feed
Start Free
Home/Insiders/KLINGENSTEIN PAUL H
KP
SEC Insider//CIK 0000935463

KLINGENSTEIN PAUL H

CIK 00009354635 companiesSAN FRANCISCO, CA
SEC Profile

Transactions

50

Companies

5

Filings

10

CIK

0000935463

Recent Transactions

50 trades
  • Award
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2021-06-10+42,223→ 42,223 total
  • Award
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2020-06-04+40,138→ 40,138 total
  • Exercise/Conversion
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2019-07-29−25,862→ 0 total
  • Exercise/Conversion
    Clovis Oncology, Inc.

    Common Stock

    2019-07-29$0.29/sh+25,862→ 59,327 total
  • Award
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2019-06-06+28,882→ 28,882 total
  • Award
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2018-10-11+14,770→ 14,770 total
  • Award
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2017-06-08+10,000→ 10,000 total
  • Award
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2016-06-09+10,000→ 10,000 total
  • Award
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2015-06-11+10,000→ 10,000 total
  • Other
    Histogen Inc.

    Common Stock

    2014-02-19−30,216→ 22,203 total
  • Other
    Histogen Inc.

    Common Stock

    2014-02-19−36,634→ 0 total
  • Other
    Histogen Inc.

    Common Stock

    2014-02-19+36,634→ 36,634 total
  • Other
    Histogen Inc.

    Common Stock

    2014-02-19+20,322→ 20,322 total
  • Other
    Histogen Inc.

    Common Stock

    2014-02-19−1,283,589→ 943,355 total
  • Other
    Histogen Inc.

    Common Stock

    2014-02-19+8,731→ 8,731 total
  • Conversion
    Histogen Inc.

    Warrant to Purchase Series A Preferred Stock

    2013-07-30−363,308→ 0 total
  • Conversion
    Histogen Inc.

    Warrant to Purchase Common Stock

    2013-07-30−42,336→ 0 total
  • Conversion
    Histogen Inc.

    Warrant to Purchase Series A Preferred Stock

    2013-07-30−5,701→ 0 total
  • Exercise of In-Money
    Histogen Inc.

    Warrant to Purchase Common Stock

    2013-07-30−1,727→ 0 total
  • Conversion
    Histogen Inc.

    Warrant to Purchase Common Stock

    2013-07-30+120→ 120 total
  • Conversion
    Histogen Inc.

    Common Stock

    2013-07-30+46,594→ 47,985 total
  • Sale
    Histogen Inc.

    Common Stock

    2013-07-30$11.00/sh−14→ 49,698 total
  • Other
    Histogen Inc.

    Common Stock

    2013-07-30$11.00/sh+251→ 49,949 total
  • Conversion
    Histogen Inc.

    Series B Preferred Stock

    2013-07-30−5,846,236→ 0 total
  • Exercise of In-Money
    Histogen Inc.

    Warrant to Purchase Common Stock

    2013-07-30−73,395→ 0 total
  • Exercise of In-Money
    Histogen Inc.

    Common Stock

    2013-07-30$0.08/sh+73,395→ 2,111,930 total
  • Purchase
    Histogen Inc.

    Common Stock

    2013-07-30$11.00/sh+104,952→ 2,226,944 total
  • Conversion
    Histogen Inc.

    Series A Preferred Stock

    2013-07-30−246,775→ 0 total
  • Award
    Histogen Inc.

    Stock Option (right to buy)

    2013-07-30+30,000→ 30,000 total
  • Conversion
    Histogen Inc.

    Series B Preferred Stock

    2013-07-30−137,626→ 0 total
  • Conversion
    Histogen Inc.

    Warrant to Purchase Series B Preferred Stock

    2013-07-30−997→ 0 total
  • Conversion
    Histogen Inc.

    Common Stock

    2013-07-30+1,979,321→ 2,038,535 total
  • Other
    Histogen Inc.

    Common Stock

    2013-07-30$11.00/sh+10,614→ 2,121,992 total
  • Purchase
    Histogen Inc.

    Common Stock

    2013-07-30$11.00/sh+2,470→ 52,419 total
  • Conversion
    Histogen Inc.

    Series A Preferred Stock

    2013-07-30−10,483,166→ 0 total
  • Conversion
    Histogen Inc.

    Warrant to Purchase Series A Preferred Stock

    2013-07-30−242,205→ 0 total
  • Sale
    Histogen Inc.

    Common Stock

    2013-07-30$11.00/sh−552→ 2,111,378 total
  • Exercise of In-Money
    Histogen Inc.

    Common Stock

    2013-07-30$0.08/sh+1,727→ 49,712 total
  • Conversion
    Histogen Inc.

    Warrant to Purchase Common Stock

    2013-07-30+73,395→ 73,395 total
  • Conversion
    Histogen Inc.

    Warrant to Purchase Common Stock

    2013-07-30+5,131→ 5,131 total
  • Conversion
    Histogen Inc.

    Warrant to Purchase Series A Preferred Stock

    2013-07-30−8,552→ 0 total
  • Conversion
    Histogen Inc.

    Warrant to Purchase Common Stock

    2013-07-30+1,727→ 1,727 total
  • Award
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2013-06-13+12,414→ 12,414 total
  • Award
    Anacor Pharmaceuticals, Inc.

    Stock Option (right to buy)

    2013-06-06+15,000→ 15,000 total
  • Award
    ReShape Weightloss Inc.

    Stock Option (right to buy)

    2013-05-08+10,000→ 10,000 total
  • Award
    Clovis Oncology, Inc.

    Stock Option (right to buy)

    2012-06-14+12,414→ 12,414 total
  • Award
    Anacor Pharmaceuticals, Inc.

    Stock Option (right to buy)

    2012-05-30+12,500→ 12,500 total
  • Award
    ReShape Weightloss Inc.

    Stock Option (right to buy)

    2012-05-09+10,000→ 10,000 total
  • Conversion
    Clovis Oncology, Inc.

    Series B Preferred Stock

    2011-11-21−1,097,661→ 0 total
  • Purchase
    Clovis Oncology, Inc.

    Common Stock

    2011-11-21$13.00/sh+391,478→ 1,278,156 total

Companies

5

Recent Filings

10

Address

ONE EMBARCADERO CENTER, SUITE 4000

SAN FRANCISCO, CA, 94111

View on SEC.gov